Open AccessNintedanib Receives Orphan Drug Designation for Mesothelioma
Publication year - 2017
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000513057.30923.77
Subject(s) - orphan drug , nintedanib , mesothelioma , medicine , library science , computer science , bioinformatics , biology , pathology , idiopathic pulmonary fibrosis , lung